• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

    6/7/24 9:30:32 AM ET
    $BBCP
    $GEN
    $HALO
    $MTN
    Engineering & Construction
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $BBCP alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

    • JP Morgan analyst Matthew Boss downgraded the rating for Vail Resorts, Inc. (NYSE:MTN) from Neutral to Underweight, while cutting the price target from $217 to $176. Vail Resorts shares gained 0.6% to close at $193.95 on Thursday. See how other analysts view this stock.
    • Morgan Stanley analyst Hamza Fodderwala downgraded Gen Digital Inc. (NASDAQ:GEN) from Overweight to Equal-Weight and slashed the price target from $28 to $27. Gen Digital shares fell 0.1% to settle at $25.44 on Thursday. See how other analysts view this stock.
    • Piper Sandler analyst Joseph Catanzaro downgraded the rating for Halozyme Therapeutics, Inc. (NASDAQ:HALO) from Overweight to Neutral, but raised the price target from $48 to $51. Halozyme Therapeutics shares rose 12.7% to settle at $51.44 on Thursday. See how other analysts view this stock. See how other analysts view this stock.
    • Truist Securities analyst Neal Dingmann downgraded Exxon Mobil Corporation (NYSE:XOM) from Buy to Hold and cut the price target from $146 to $124. Exxon Mobil shares rose 0.8% to close at $113.97 on Thursday. See how other analysts view this stock.
    • William Blair analyst Tim Mulrooney downgraded the rating for Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) from Outperform to Market Perform. Concrete Pumping shares rose 0.7% to settle at $7.53 on Thursday. See how other analysts view this stock.

    Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Risk Off Stocks Delivering High-Dividend Yields

    Get the next $BBCP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BBCP
    $GEN
    $HALO
    $MTN

    CompanyDatePrice TargetRatingAnalyst
    Exxon Mobil Corporation
    $XOM
    2/3/2026$125.00Neutral → Underperform
    BNP Paribas Exane
    Exxon Mobil Corporation
    $XOM
    2/3/2026$135.00 → $145.00Buy
    TD Cowen
    Vail Resorts Inc.
    $MTN
    1/13/2026$165.00Hold → Buy
    Jefferies
    Exxon Mobil Corporation
    $XOM
    12/12/2025$128.00 → $135.00Buy
    TD Cowen
    Exxon Mobil Corporation
    $XOM
    12/8/2025$114.00Underperform → Neutral
    BNP Paribas Exane
    Halozyme Therapeutics Inc.
    $HALO
    12/4/2025$56.00Neutral → Sell
    Goldman
    Exxon Mobil Corporation
    $XOM
    10/17/2025$156.00Overweight
    Wells Fargo
    Halozyme Therapeutics Inc.
    $HALO
    10/14/2025$70.00Underperform → Market Perform
    Leerink Partners
    More analyst ratings

    $BBCP
    $GEN
    $HALO
    $MTN
    SEC Filings

    View All

    SEC Form 10-K filed by Halozyme Therapeutics Inc.

    10-K - HALOZYME THERAPEUTICS, INC. (0001159036) (Filer)

    2/17/26 4:08:23 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Halozyme Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HALOZYME THERAPEUTICS, INC. (0001159036) (Filer)

    2/17/26 4:04:55 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Vail Resorts Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - VAIL RESORTS INC (0000812011) (Filer)

    2/12/26 4:50:32 PM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $BBCP
    $GEN
    $HALO
    $MTN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Exxon Mobil downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Exxon Mobil from Neutral to Underperform and set a new price target of $125.00

    2/3/26 6:52:02 AM ET
    $XOM
    Integrated oil Companies
    Energy

    TD Cowen reiterated coverage on Exxon Mobil with a new price target

    TD Cowen reiterated coverage of Exxon Mobil with a rating of Buy and set a new price target of $145.00 from $135.00 previously

    2/3/26 6:36:50 AM ET
    $XOM
    Integrated oil Companies
    Energy

    Vail Resorts upgraded by Jefferies with a new price target

    Jefferies upgraded Vail Resorts from Hold to Buy and set a new price target of $165.00

    1/13/26 8:44:26 AM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $BBCP
    $GEN
    $HALO
    $MTN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gen and Vercel Partner to Bring Independent Safety Verification to the AI Skills Ecosystem

    Gen's Agent Trust Hub will bring risk verification to skills.sh, protecting developers and users from unsafe AI skillsMOUNTAIN VIEW, Calif., Feb. 17, 2026 /PRNewswire/ -- As AI agents evolve from assistants into autonomous digital actors capable of executing real-world tasks, Gen (NASDAQ:GEN) today announced a strategic partnership with Vercel to bring independent safety verification to the growing AI skills ecosystem at https://skills.sh/. Vercel's platform serves more than 6 million developers worldwide, and skills.sh – its open directory for reusable AI agent skills – serves as a discovery layer where developers can publish and install modular capabilities that extend what AI agents can d

    2/17/26 5:24:00 PM ET
    $GEN
    Computer Software: Prepackaged Software
    Technology

    HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE

    Full Year 2025 Total Revenue Increased 38% YOY to Record $1.397 billionFull Year 2025 Royalty Revenue Increased 52% YOY to Record $868 millionCompleted Acquisitions of Elektrofi's Hypercon™ Technology and Surf Bio's Hyperconcentration TechnologyReiterating 2026 Financial Guidance Ranges:Total Revenue of $1.710 - $1.810 billion, YOY Growth of 22% - 30%Adjusted EBITDA of $1.125 - $1.205 billion, YOY Growth of 71% - 83%1Non-GAAP Diluted EPS of $7.75 - $8.25, YOY Growth of 87% - 99%1SAN DIEGO, Feb. 17, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today reported its financial and operating results for the full year and fourth quarter ended December 

    2/17/26 4:01:00 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    ExxonMobil to Speak at Morgan Stanley Energy & Power Conference

    Exxon Mobil Corporation (NYSE:XOM) today announced Jack Williams, Senior Vice President, will conduct a fireside chat at the Morgan Stanley Energy & Power Conference in New York on March 3, 2026, at 11:00 a.m. ET. To access the live webcast, visit the event page. An archived audio portion of the webcast will be available on the ExxonMobil website approximately 24 hours after the event. About ExxonMobil ExxonMobil, one of the largest publicly traded international energy and petrochemical companies, creates solutions that improve quality of life and meet society's evolving needs. The corporation's primary businesses - Upstream, Product Solutions and Low Carbon Solutions – provide prod

    2/17/26 10:15:00 AM ET
    $XOM
    Integrated oil Companies
    Energy

    $BBCP
    $GEN
    $HALO
    $MTN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, CHIEF LEGAL OFFICER Snyder Mark Howard converted options into 16,812 shares and covered exercise/tax liability with 9,068 shares, increasing direct ownership by 23% to 41,925 units (SEC Form 4)

    4 - HALOZYME THERAPEUTICS, INC. (0001159036) (Issuer)

    2/17/26 6:53:47 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SVP, CHIEF FINANCIAL OFFICER Labrosse Nicole converted options into 23,773 shares and covered exercise/tax liability with 12,894 shares, increasing direct ownership by 49% to 32,958 units (SEC Form 4)

    4 - HALOZYME THERAPEUTICS, INC. (0001159036) (Issuer)

    2/17/26 6:52:46 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    PRESIDENT AND CEO Torley Helen converted options into 89,055 shares and covered exercise/tax liability with 48,043 shares, increasing direct ownership by 6% to 749,731 units (SEC Form 4)

    4 - HALOZYME THERAPEUTICS, INC. (0001159036) (Issuer)

    2/17/26 6:51:29 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BBCP
    $GEN
    $HALO
    $MTN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chrystal John C bought $135,693 worth of shares (5,000 units at $27.14), increasing direct ownership by 21% to 28,419 units (SEC Form 4)

    4 - Gen Digital Inc. (0000849399) (Issuer)

    11/14/25 5:16:56 PM ET
    $GEN
    Computer Software: Prepackaged Software
    Technology

    EVP & Chief Financial Officer Korch Angela A bought $32,550 worth of shares (210 units at $155.00), increasing direct ownership by 4% to 4,905 units (SEC Form 4)

    4 - VAIL RESORTS INC (0000812011) (Issuer)

    10/7/25 6:55:45 PM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Director Chrystal John C bought $321,000 worth of shares (10,000 units at $32.10), increasing direct ownership by 345% to 12,901 units (SEC Form 4)

    4 - Gen Digital Inc. (0000849399) (Issuer)

    8/15/25 4:25:56 PM ET
    $GEN
    Computer Software: Prepackaged Software
    Technology

    $BBCP
    $GEN
    $HALO
    $MTN
    Leadership Updates

    Live Leadership Updates

    View All

    Gen Launches Agent Trust Hub for Safer Agentic Era

    Following viral introduction of OpenClaw, data reveals more than 18,000 instances open for attack MOUNTAIN VIEW, Calif., Feb. 4, 2026 /PRNewswire/ -- Gen (NASDAQ:GEN), a global leader powering Digital Freedom with a family of trusted brands including Norton, Avast, LifeLock, MoneyLion and more, today announced the launch of the Gen Agent Trust Hub, a new security platform designed for safer autonomous AI agent adoption. Gen is squarely positioned to provide the trust layer in the AI Agentic Era.  Autonomous agents – AI that can read emails, manage financial workflows, and act

    2/4/26 9:00:00 AM ET
    $GEN
    Computer Software: Prepackaged Software
    Technology

    Jim Lang Elected to Halozyme's Board of Directors

    SAN DIEGO, Dec. 8, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Jim Lang to its Board of Directors. Mr. Lang brings more than 30 years of executive leadership experience in healthcare, life sciences, business services and data analytics. "Jim brings extensive experience in building and scaling innovative healthcare businesses, and we are delighted to welcome him to the Halozyme board," said Dr. Helen Torley, president and chief executive officer. "His strategic insight and proven ability to drive growth, including through M&A, will be a tremendous asset as we deliver on our growth strategy and create meaningful new value for our

    12/8/25 4:05:00 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Vail Resorts Appoints Celeste Burgoyne as Chief Revenue Officer

    Seasoned business leader and lululemon executive joins the Company to help drive the next chapter of growth BROOMFIELD, Colo., Nov. 21, 2025 /PRNewswire/ -- Vail Resorts, Inc. (NYSE:MTN) today announced that Celeste Burgoyne, current President of the Americas and Global Guest Innovation for lululemon, has been appointed Executive Vice President & Chief Revenue Officer, effective January 26, 2026, to help drive the next chapter of growth for Vail Resorts. Burgoyne will oversee Vail Resorts' marketing function, lead all aspects of the guest journey and digital experience, and be directly responsible for the majority of the Company's revenue.

    11/21/25 8:30:00 AM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $BBCP
    $GEN
    $HALO
    $MTN
    Financials

    Live finance-specific insights

    View All

    HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE

    Full Year 2025 Total Revenue Increased 38% YOY to Record $1.397 billionFull Year 2025 Royalty Revenue Increased 52% YOY to Record $868 millionCompleted Acquisitions of Elektrofi's Hypercon™ Technology and Surf Bio's Hyperconcentration TechnologyReiterating 2026 Financial Guidance Ranges:Total Revenue of $1.710 - $1.810 billion, YOY Growth of 22% - 30%Adjusted EBITDA of $1.125 - $1.205 billion, YOY Growth of 71% - 83%1Non-GAAP Diluted EPS of $7.75 - $8.25, YOY Growth of 87% - 99%1SAN DIEGO, Feb. 17, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today reported its financial and operating results for the full year and fourth quarter ended December 

    2/17/26 4:01:00 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Vail Resorts Announces Fiscal 2026 Second Quarter Earnings Release Date

    BROOMFIELD, Colo., Feb. 13, 2026 /PRNewswire/ -- Vail Resorts, Inc. (NYSE:MTN) announced today it will release the Company's financial results for its fiscal second quarter 2026 ended January 31, 2026 after market close on Monday, March 9, 2026. The Company will host a conference call at 5:00 p.m. Eastern Time that same day during which Company executives will review the financial results. The call will be broadcast at investors.vailresorts.com. Those wishing to participate via telephone should dial (800) 225-9448 to be connected. Callers outside of the U.S. or Canada should dial +1 (203) 518-9708. The conference ID is MTNQ226. In addition, a replay of the call will be available two hours fo

    2/13/26 4:05:00 PM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Halozyme to Report Fourth Quarter and Full Year 2025 Financial and Operating Results

    SAN DIEGO, Feb. 10, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2025 financial and operating results on Tuesday, February 17, 2026, following the close of trading. Halozyme will host a conference call on Tuesday, February 17, 2026 at 1:30pm PT/4:30pm ET to discuss the results. The conference call may be accessed live with pre-registration via this link: https://events.q4inc.com/analyst/624893800?pwd=q3lpEa6F A live webcast and replay of the conference call will also be available through the "Investors" section of Halozyme's corporate website at www.halozyme.com. About Halozyme Halozyme is a bioph

    2/10/26 4:05:00 PM ET
    $HALO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BBCP
    $GEN
    $HALO
    $MTN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Vail Resorts Inc.

    SC 13G/A - VAIL RESORTS INC (0000812011) (Subject)

    11/14/24 4:30:51 PM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Vail Resorts Inc.

    SC 13G/A - VAIL RESORTS INC (0000812011) (Subject)

    11/14/24 2:17:28 PM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form SC 13G filed by Vail Resorts Inc.

    SC 13G - VAIL RESORTS INC (0000812011) (Subject)

    11/13/24 10:22:19 AM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $BBCP
    $GEN
    $HALO
    $MTN
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy